<p>The Food and Drug Administration (FDA) could rule this week that COVID booster shots may be distributed to Americans before the completion of testing in humans.</p>
<p>The lack of human studies for the new booster has led to concerns about its upcoming release.</p>
<p>“I’m uncomfortable that we would move forward—that we would give millions or tens of millions of doses to people—based on mouse data,” Paul Offit, an FDA adviser and director of the Vaccine Education Center at Children’s Hospital of Philadelphia, <a href="https://www.wsj.com/articles/latest-covid-boosters-are-set-to-roll-out-before-human-testing-is-completed-11661679003" target="_blank" rel="noopener">told</a> the Wall Street Journal in a report published on Sunday.</p>
<p>The updated Pfizer and BioNTech vaccine contains mRNA of the original SARS-CoV-2 spike protein found in the current vaccine together with mRNA spike protein for the Omicron BA.4/BA.5 variant. Pfizer and BioNTech said it is starting a human study of the booster shot this month, though it would not be completed until after its potential approval and distribution to Americans.</p>
<p>Pfizer and BioNTech have requested that the FDA grant an emergency use authorization for its COVID vaccine adapted to the BA.4/BA.5 versions of the Omicron variant. The emergency request would allow the booster&#8217;s approval without the traditional studies required for such a vaccine.</p>
<p>The new booster dose is intended for individuals 12 years of age and older and would be available to ship immediately, according to a news release from the company.</p>
<p>“The agility of the mRNA platform, together with extensive clinical experience with the Pfizer-BioNTech COVID-19 Vaccine, has allowed us to develop, test and manufacture updated, high-quality vaccines that align to circulating strains with unprecedented speed,” <a href="https://www.businesswire.com/news/home/20220822005376/en/Pfizer-and-BioNTech-Submit-Application-to-U.S.-FDA-for-Emergency-Use-Authorization-of-Omicron-BA.4BA.5-Adapted-Bivalent-COVID-19-Vaccine" target="_blank" rel="noopener">said</a> Albert Bourla, Chairman and CEO of Pfizer.</p>
<p>“Having rapidly scaled up production, we are positioned to immediately begin distribution of the bivalent Omicron BA.4/BA.5 boosters, if authorized, to help protect individuals and families as we prepare for potential fall and winter surges,&#8221; he added.</p>
<p>The most recent <a href="https://covid.cdc.gov/covid-data-tracker/#variant-proportions" target="_blank" rel="noopener">data</a> provided by the CDC reveals that the BA.5 variant is responsible for 88.7% of all new cases between August 21 and August 27. The BA.4 variant included an additional 3.6% of new cases.</p>
<p>In addition to Pfizer/BioNTech, Moderna has also requested FDA approval for its updated COVID vaccine targeting the latest coronavirus strains. If approved, it could ship in September.</p>
<p>&#8220;We have worked closely with the FDA to ensure that Americans will have access to Moderna&#8217;s updated, bivalent booster, which, if authorized, may offer higher, broader, and more durable protection against COVID-19 compared to the currently authorized booster,&#8221; <a href="https://investors.modernatx.com/news/news-details/2022/Moderna-Completes-Application-To-U.S.-Food-And-Drug-Administration-For-Emergency-Use-Authorization-Of-Omicron-Targeting-Bivalent-Covid-19-Booster-Vaccine-mRNA-1273.222/default.aspx" target="_blank" rel="noopener">said</a> Stéphane Bancel, Chief Executive Officer of Moderna. &#8220;Moderna&#8217;s mRNA platform has enabled us to develop, study, and deploy bivalent booster vaccine candidates that demonstrate superior protection against all tested COVID variants, in record time. Our commitment to using cutting-edge science to protect the world against the ongoing COVID threat continues.&#8221;</p>
<p>Moderna noted that it launched a clinical trial of the booster earlier this month. Its press release stated that its application &#8220;is based on preclinical data as well as clinical trial data available for the company&#8217;s BA.1 Omicron-targeting bivalent booster candidate, mRNA-1273.214.&#8221;</p>
<p>Full human clinical trials are not required for emergency use approval. However, the push for booster approvals ahead of more developed human studies could cause hesitancy among some people eligible for the vaccine.</p>

<script async src="https://www.instagram.com/embed.js"></script>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<script async src="https://www.tiktok.com/embed.js"></script><div data-widget-host="revcontent" data-pub-id="165152" data-widget-id="290588"></div><script src="https://delivery.revcontent.com/165152/290588/widget.js"></script>

Report: COVID Boosters Could Be Authorized For Use Before Human Testing Is Completed

CONTINUE READING

District Judge Blocks California’s COVID ‘Misinformation’ Law

New York GOP Leaders Demand Answers For Migrant Relocation In Upstate Town

Arkansas Senate Bill Classifies Drag Shows As ‘Adult-Oriented Businesses’ In Effort To Protect Children

‘Subject To Felony Prosecution’: Gov. Kristi Noem Warns South Dakota Pharmacists Against Dispensing Abortion Pills

Ted Cruz Introduces Bill To Block Non-Citizens From Voting In Washington, D.C.

Ted Cruz Introduces Constitutional Amendment To Enforce Term Limits For Congress

News

COVID

COVID-19 Vaccine

Health

A video goes viral showing a baby being refused his mother by two gay "dads". This is just the tip of the iceberg, which is why we will have an important discussion today about surrogacy. 

Hour 1

The Matt Walsh Show

Ep. 1765 - This Video Is One Of The Worst Things I've Seen In A Long Time 

The Strait of Hormuz officially opens for business (kind of), the Pope makes “shocking” comments on immigration, and President Trump promises UFO disclosure at TPUSA. 


The Michael Knowles Show

Ep. 1956 -  Pope Leo's "SHOCKING" Immigration Comments EXPLAINED

A false miscreed has corrupted our leadership class.


The Andrew Klavan Show

Ep. 1275 - Dumb, Dumber and Progressive

President Trump announces a 10-day ceasefire between Lebanon and Israel, a murder-suicide involving former Democratic Lieutenant Governor Justin Fairfax shakes Virginia, and France and Britain hold a conference to secure the Strait of Hormuz – after the Iranian conflict ends. Get the facts first with Morning Wire.

- - -

Ep. 2738

- - -

Wake up with new Morning Wire merch: https://bit.ly/4lIubt3

- - -

Today's Sponsors:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.

Pocket Hose - Text MORNING to 64000 to get a FREE pocket pivot and their 10-pattern sprayer with the purchase of ANY size Copper Head hose. Message and data rates may apply.

Morning Wire

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26 [Member Exclusive]

A ceasefire goes into effect between Israel and Lebanon, a tragic murder-suicide rocks Virginia, and Dairy Queen deploys AI in the drive-thru. Get the facts first with Evening Wire.
- - -
Ep. 2737
- - -
Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 
- - -
Today’s Sponsor:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text “WIRE” to 83848 to learn more.


Evening Wire: Lebanon Ceasefire Begins & Murder-Suicide Rocks VA | 4.16.26

The Pendragon Cycle

Menu

— News —

Report: COVID Boosters Could Be Authorized For Use Before Human Testing Is Completed